Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lyell Immunopharma
Biotech
Lyell loses 25% of staff, CMO to conserve cash post-GSK collab
A year after Lyell Immunopharma lost a $1 billion biobucks partnership with GSK, the cell therapy biotech is offloading a quarter of its staff.
James Waldron
Nov 8, 2023 7:41am
EMD Serono taps new COO—Chutes & Ladders
Jul 7, 2023 9:30am
GSK pays out £30M to Adaptimmune as cell therapy work ends
Apr 11, 2023 11:47am
Roche's executive dominoes continue to tip—Chutes & Ladders
Dec 16, 2022 9:30am
GSK severs Immatics partnership in further T-cell retreat
Nov 17, 2022 11:00am
GSK axes Lyell cell therapy, passes programs to Adaptimmune
Oct 25, 2022 9:10am